Congressman Wenstrup Tours UC Neuroscience Lab
U.S. Rep. Brad Wenstrup, who represents Ohios 2nd District in the U.S. House of Representatives, visited the UC College of Medicine Thursday, Sept. 3, for a laboratory tour and neuroscience research discussion.
Wenstrup began his visit in the CARE/Crawley Building with a tour of the Selma Schottenstein Harris Laboratory for Research in Parkinson's, which is directed by Kim Seroogy, PhD. Seroogy, a professor in the Department of Neurology and Rehabilitation Medicine and vice chair of basic research in the department, is a member of the research team at the UC Neuroscience Institutes James J. and Joan A. Gardner Center for Parkinsons Disease and Movement Disorders.
During the tour, Seroogy gave an overview of his research, which examines the effects of stress and depression on the progression of Parkinsons disease. Seroogy was accompanied by the Society for Neuroscience 2015 Early Career Policy Fellow Ryan Makinson, a doctoral student in neuroscience who helped coordinate Wenstrups visit.
Following the lab tour, Wenstrup, Seroogy and Makinson participated in a discussion of posttraumatic stress disorder (PTSD) research at UC and partnerships with the Cincinnati Department of Veterans Affairs (VA) Medical Center with Melanie Cushion, PhD, senior associate dean for research of the College of Medicine; Marshall "Chip Montrose, PhD, vice provost and dean of the graduate school; Renu Sah, PhD, associate professor in the Department of Psychiatry and Behavioral Neuroscience; Mike Carroll, assistant vice president for government relations; and Greg Vehr, vice president for government relations. The panel also stressed the importance of increasing federal funding of biomedical research.
Wenstrup is a member of the U.S. Army Reserve with service in Iraq and has treated patients as a podiatric surgeon for the past 26 years. He posted on Twitter about his visit, saying, "Great tour, always good to see what's happening at UC!"
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.